Omega-3 Fish Oil
Salmon, sardines, mackerel, herring, anchovies.
Tag
ADHD and attention references connect nutrient-status topics, sleep context, and evidence-limited supplements studied in ADHD or attention-related outcomes. This page is a research navigation aid, not ADHD treatment guidance.
| Item | Type | Relationship | Evidence |
|---|---|---|---|
| Omega-3 Fish Oil | bioactive | Caution / Limited Evidence | NCCIH and Cochrane summarize ADHD omega-3/PUFA evidence as mixed or limited; use this as a research topic, not a treatment claim. Traditional / Safety Reference |
| Iron | nutrient | Deficiency Sign | Systematic reviews link ADHD with lower ferritin or iron-deficiency context, while supplementation evidence remains low certainty and safety-sensitive. Systematic Review |
| Zinc | nutrient | May Support | Zinc belongs in ADHD research navigation because of nutrient-role biology and limited clinical literature; excessive zinc can impair copper status. Official Reference |
| Vitamin D | nutrient | Caution / Limited Evidence | Meta-analysis evidence is observational and describes the association as equivocal; vitamin D excess can be harmful. Systematic Review |
| Magnesium | nutrient | May Support | Official nutrient-role framing from NIH ODS; ADHD-specific use should remain a review topic rather than a recommendation. Official Reference |
| Caffeine | bioactive | Possible Side Effect | FDA caffeine safety context; sleep disruption can worsen attention even when short-term alertness improves. Government Health Agency |
| Bacopa | bioactive | Caution / Limited Evidence | Cognition meta-analysis evidence is not the same as ADHD treatment evidence; keep claims conservative. Systematic Review |
Salmon, sardines, mackerel, herring, anchovies.
Red meat and shellfish, Legumes, Fortified cereals, Leafy greens.
Oysters and meat, Dairy foods, Legumes and seeds.
Fatty fish, Fortified milk or plant beverages, Egg yolk.
Nuts and seeds, Legumes, Whole grains, Leafy green vegetables.
Coffee, tea, yerba mate, guarana, cacao.
Bacopa monnieri aerial parts.
Omega-3 and other PUFA supplements have been studied in ADHD, but higher-quality summaries describe benefits as uncertain or modest and less effective than conventional ADHD treatments. | blood thinners | bleeding risk | surgery
Low ferritin or iron deficiency may be more common in children with ADHD in observational research, but iron supplementation should be based on testing and clinician guidance because excess iron can be dangerous. | Iron overdose can be dangerous, especially for children. High-dose use should be guided by a clinician.
Zinc is involved in normal nervous-system and immune function and has been studied in ADHD contexts, but broad supplementation claims should stay conservative. | Long-term high-dose zinc can interfere with copper status.
Vitamin D status has observational links with ADHD, but this does not prove that vitamin D supplementation treats ADHD. Testing and ordinary DRI/UL safety context still matter. | Avoid chronic high-dose use above the UL without medical supervision.
Magnesium supports normal nerve and muscle function and is often discussed in attention or sleep contexts, but ADHD-specific supplement claims need stronger evidence review. | The DRI UL applies to supplemental/pharmacological magnesium, not magnesium naturally present in food and water.
Caffeine can affect alertness and sleep. In attention contexts, total caffeine, timing, anxiety, sleep disruption, blood pressure, and age matter. | pregnancy/breastfeeding | sleep | anxiety
Bacopa is studied for memory and attention outcomes, but this should not be generalized to ADHD treatment without stronger ADHD-specific evidence and safety review. | sedatives | pregnancy/breastfeeding
These are the dated references used for this tag. Live research searches can change; these links explain the fixed wording shown on this page.
National Center for Complementary and Integrative Health | Acquired 2026-08-02 | Traditional / Safety Reference
ADHD complementary health framing, Omega-3 ADHD evidence limitations, Melatonin and sleep context.
Cochrane | Acquired 2026-08-02 | Academic Review
Omega-3 and PUFA ADHD evidence, Children and adolescents, ADHD symptom evidence limitations.
NIH Office of Dietary Supplements | Acquired 2026-07-23 | Official Reference
ALA AI, EPA/DHA no official DRI, Fish, krill, algal, and plant omega sources.
Scientific Reports / PubMed | Acquired 2026-08-02 | Systematic Review
ADHD and ferritin association, Iron deficiency context, Children and adolescents.
Journal of Neuropsychiatry and Clinical Neurosciences / PubMed | Acquired 2026-08-02 | Systematic Review
Iron supplementation and ADHD evidence limitations, Neurodevelopmental disorders, Iron overdose caution.
NIH Office of Dietary Supplements | Acquired 2026-07-23 | Official Reference
Heme and non-heme iron, Iron supplement forms, Elemental iron context.
NIH Office of Dietary Supplements | Acquired 2026-07-23 | Official Reference
Zinc supplement forms, Elemental zinc context, Zinc absorption and iron interaction.
National Center for Complementary and Integrative Health | Acquired 2026-08-02 | Traditional / Safety Reference
ADHD conventional treatment context, ADHD supplement evidence limitations, St. John's wort interaction caution.
Advances in Nutrition / PubMed Central | Acquired 2026-08-02 | Systematic Review
Vitamin D status and ADHD association, Observational evidence limitations, 25-hydroxyvitamin D context.
Health Canada | Acquired 2026-07-23 | Official Reference
Canadian DRI table display, Vitamin D and K reference values, Vitamin K no-UL caution.
European Food Safety Authority | Acquired 2026-07-23 | Official Reference
EU vitamin D adequate intake, 25(OH)D target context, Minimal sun exposure assumption.
NIH Office of Dietary Supplements | Acquired 2026-07-23 | Official Reference
Magnesium supplement forms, Magnesium bioavailability, Magnesium medication interactions.
U.S. Food and Drug Administration | Acquired 2026-07-23 | Government Health Agency
Caffeine safety-limit context.
PubMed | Acquired 2026-07-26 | Systematic Review
Bacopa, Cognition, Attention speed.
Zinc is involved in normal nervous-system and immune function and has been studied in ADHD contexts, but broad supplementation claims should stay conservative.
Evidence note: Zinc belongs in ADHD research navigation because of nutrient-role biology and limited clinical literature; excessive zinc can impair copper status.
Sources: Zinc Fact Sheet for Health Professionals (2026-07-23)Official Reference, Attention-Deficit Hyperactivity Disorder at a Glance (2026-08-02)Traditional / Safety Reference
Magnesium supports normal nerve and muscle function and is often discussed in attention or sleep contexts, but ADHD-specific supplement claims need stronger evidence review.
Evidence note: Official nutrient-role framing from NIH ODS; ADHD-specific use should remain a review topic rather than a recommendation.
Sources: Magnesium Fact Sheet for Health Professionals (2026-07-23)Official Reference, ADHD and Complementary Health Approaches (2026-08-02)Traditional / Safety Reference
Low ferritin or iron deficiency may be more common in children with ADHD in observational research, but iron supplementation should be based on testing and clinician guidance because excess iron can be dangerous.
Evidence note: Systematic reviews link ADHD with lower ferritin or iron-deficiency context, while supplementation evidence remains low certainty and safety-sensitive.
Sources: Peripheral Iron Levels in Children With Attention-Deficit Hyperactivity Disorder: Systematic Review and Meta-Analysis (2026-08-02)Systematic Review, Iron Supplementation in Management of Neurodevelopmental Disorders: Systematic Review, Meta-Analysis, and Qualitative Synthesis (2026-08-02)Systematic Review, Iron Fact Sheet for Health Professionals (2026-07-23)Official Reference
Caffeine can affect alertness and sleep. In attention contexts, total caffeine, timing, anxiety, sleep disruption, blood pressure, and age matter.
Evidence note: FDA caffeine safety context; sleep disruption can worsen attention even when short-term alertness improves.
Sources: Spilling the Beans: How Much Caffeine is Too Much? (2026-07-23)Government Health Agency, ADHD and Complementary Health Approaches (2026-08-02)Traditional / Safety Reference
Omega-3 and other PUFA supplements have been studied in ADHD, but higher-quality summaries describe benefits as uncertain or modest and less effective than conventional ADHD treatments.
Evidence note: NCCIH and Cochrane summarize ADHD omega-3/PUFA evidence as mixed or limited; use this as a research topic, not a treatment claim.
Sources: ADHD and Complementary Health Approaches (2026-08-02)Traditional / Safety Reference, Polyunsaturated Fatty Acids for Attention Deficit Hyperactivity Disorder in Children and Adolescents (2026-08-02)Academic Review, Omega-3 Fatty Acids Fact Sheet for Health Professionals (2026-07-23)Official Reference
Vitamin D status has observational links with ADHD, but this does not prove that vitamin D supplementation treats ADHD. Testing and ordinary DRI/UL safety context still matter.
Evidence note: Meta-analysis evidence is observational and describes the association as equivocal; vitamin D excess can be harmful.
Sources: Vitamin D Status and Attention Deficit Hyperactivity Disorder: Systematic Review and Meta-Analysis of Observational Studies (2026-08-02)Systematic Review, Dietary Reference Intakes Tables: Reference Values for Vitamins (2026-07-23)Official Reference, Dietary Reference Values for Vitamin D (2026-07-23)Official Reference
Bacopa is studied for memory and attention outcomes, but this should not be generalized to ADHD treatment without stronger ADHD-specific evidence and safety review.
Evidence note: Cognition meta-analysis evidence is not the same as ADHD treatment evidence; keep claims conservative.
Sources: Meta-Analysis of Randomized Controlled Trials on Cognitive Effects of Bacopa Monnieri Extract (2026-07-26)Systematic Review, Attention-Deficit Hyperactivity Disorder at a Glance (2026-08-02)Traditional / Safety Reference